Axial Spondyloarthritis

Although the seroprevalence of SARS-CoV-2 in patients with immune-mediated inflammatory diseases is comparable to the general population, increased systemic inflammation among these patients is linked to symptomatic COVID-19, according to researchers.

Women demonstrate higher axial spondyloarthritis disease burden, and more peripheral symptoms, than men, according to data published in The Journal of Clinical Rheumatology.

Researchers found significantly lower treatment rates for women with ankylosing spondyloarthritis in multiple studies analyzing clinical trials in axial spondylarthritis, resulting in poor outcomes and response to therapies once started.

High disease activity and widespread pain in patients with axial spondyloarthritis are associated with the development of fibromyalgia, according to data published in Rheumatology.

Among patients with axial spondyloarthritis, disease activity surpassed other ‘key drivers’ such as enthesitis, gender and spinal mobility in explaining disability, according to data published in Arthritis Care & Research.

There were approximately 1.3 billion cases of musculoskeletal disorders worldwide in 2017, leading to 121,300 deaths and 138.7 million disability adjusted life years, according to findings published in Arthritis & Rheumatology.

How common is asymptomatic bowel involvement in patients with peripheral or axial SpA? Can we use NSAIDs in these patients? What’s the difference between sulfasalazine and mesalamine? Hear what a rheumatologist should know about IBD!

Strong data for two interleukin-17 inhibitors have given a lift to clinicians treating the spondyloarthropathies, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

Patients with complex, but not well-known diseases often find themselves at a loss for two important things: A voice and access to reliable information about their condition. Interestingly, the physicians who treat these patients often feel the same way.

Baseline smoking is strongly associated with worse MRI sacroiliac joint inflammation among blue-collar or “low education” patients with axial spondyloarthritis, according to data published in Arthritis & Rheumatology.